Genetic Polymorphisms of CYP2C19 and Resistance to Clopidogrel Therapy among Iranian Patients Suffering from Ischemic Heart Disease

Background: Clopidogrel is a standout amongst the most ordinarily recommended medications to avoid ischemic occasions taking after coronary disorder or stant position. However, impaired responses the therapy as well as resistance to the therapy have also been reported. Genetic variants play an impor...

Full description

Bibliographic Details
Main Authors: Behzad Poopak, Maed Heidari, Parviz Fallah, Nazila Safari, Saghar Rabieipoor, Zahra Amiri, Shahram Taghdisi
Format: Article
Language:English
Published: Mazandaran University of Medical Sciences and Health Services 2016-07-01
Series:Research in Molecular Medicine
Subjects:
Online Access:http://rmm.mazums.ac.ir/browse.php?a_code=A-10-828-1&slc_lang=en&sid=1